Literature DB >> 23823874

Studies on the alkaloids of the bark of Magnolia officinalis: isolation and on-line analysis by HPLC-ESI-MS(n).

Renyi Yan1, Weihao Wang, Jian Guo, Hongliang Liu, Jianyong Zhang, Bin Yang.   

Abstract

The bark of Magnolia officinalis is a well-known Traditional Chinese Medicine. In the present study, two new n class="Chemical">alkaloids, named (S)-4-keto-magnoflorine (6) and (R)-3,4-dehydromagnocurarine (11), together with seven known alkaloids: (S)-magnoflorine (5), trans/cis N-feruloylputrescine (7/8), (R)-magnocurarine (10), (S)-tembetarine (12), (R)-oblongine (14), and (R)-asimilobine (17) were isolated and their structures elucidated by spectroscopic methods, including 1D, 2D NMR, and HRESI-MS. The absolute configurations of the isoquinoline alkaloids 5, 6, 10-12, 14, and 17 were determined by CD. In vitro inhibitory activities against aldose reductase, lipase, α-glucosidase, DPP-IV and three cancer cell lines (A549, Bel-7402, and HCT-8) were evaluated for all isolated compounds. However, all compounds showed weak activities in all tests at the same concentration as the positive control drugs. An HPLC-ESI-MS(n) method has been established for screening of alkaloids in the bark of M. officinalis. A total of 23 alkaloids were identified or tentatively characterized; including 13 aporphines, eight benzylisoquinolines and two amides. Plausible fragmentation pathways of the representative compounds 6, 7/8, 11, and 17 were proposed in the present study.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23823874      PMCID: PMC6270518          DOI: 10.3390/molecules18077739

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


1. Introduction

The bark of Magnolia officinalis (Magnoliaceae), called n class="Chemical">Houpu in Chinese, has a very wide range of applications. It’s a common ingredient in the treatment of abdominal swelling of various causes and edema. Many of the prescriptions containing Houpu are also aimed at treatment of lung disorders (including cough and asthma) or intestinal disorders [1,2]. Besides the well-known lignans magnolol and honokiol being the active compounds of M. officinalis, alkaloids are a group of interesting secondary metabolites of this species, which produces mainly isoquinoline-type alkaloids, the majority of which are aporphine and benzylisoquinoline derivatives [3,4,5,6]. In a previous paper from our group, 11 polar compounds including one major alkaloidmagnoflorine—have been isolated from the stem bark of M. officinalis [7]. In connection with our interest in the alkaloids of this plant, a further chemical study focusing on an alkaloids-enriched fraction has been conducted. The strategy of this study includes two steps: (1) isolation of main components and complete structural characterization by NMR, MS, and CD spectroscopies. (2) on-line identification of alkaloids by comparing retention time and MSn data. Twenty three alkaloids were identified or tentatively characterized, including 13 aporphines, eight benzylisoquinolines and two amides. Two new alkaloids, named (S)-4-keto-magnoflorine (6) and (R)-3,4-dehydromagnocurarine (11), together with seven known alkaloids were isolated (Figure 1).
Figure 1

Structures of compounds 1–23.

Structures of compounds 1–23.

2. Results and Discussion

2.1. Structure Elucidation of the Purified Compounds

Compound 6 was obtained as a white amorphous powder. The molecular formula was determined to be n class="Chemical">C20H22O5N from its HRESI-MS (m/z 356.1514 [M]+; calcd for C20H22O5N, 356.1498) and NMR data. The 1H-NMR spectrum showed two adjacent aromatic protons at δH 6.55 (1H, d, J = 8.0 Hz) and 6.40 (1H, d, J = 8.0 Hz), and one isolated aromatic proton at δH 6.87 (1H, s), which were ascribed to the hydrogens of A and D ring of the aporphine nucleus. Singlets at δH 3.75 (3H, s) and 3.70 (3H, s) attributed to methoxy groups. The signals at δH 3.31 (3H, s) and 2.82 (3H, s) indicated the presence of two N,N-dimethyl groups in the molecule. The 13C-NMR data together with a HSQC experiment indicated the presence of 20 n class="Chemical">carbons in 6, comprising one ketone carbon at δC 187.4, 12 aromatic carbons between δC 165.2 and 107.2, four methyl groups at δC 58.1, 58.0, 56.2, and 48.0, two methylenes at δC 69.9 and 31.5, and one methine at δC 71.4. The NMR data were similar to those of magnoflorine [8], except for the ketone carbon signal and the low field hydrogen signal at δH 3.91 (2H, s). The long-range 1H-13C correlation observed between H-3 (δH 6.87, s) and δC 187.4 confirmed the substitution at C-4 (Figure 2). The NOE correlations between H-3 and δH 3.70 (3H, s), between H-9 and δH 3.75 (3H, s) confirmed the location of methoxys. The absolute configuration of C-6a was established as S by the circular dichroism (CD) spectrum, which showed a positive Cotton effect at 235 nm [9]. Thus, the structure of 6 was elucidated as (S)-4-keto-magnoflorine. Compound 11 was obtained as a white amorphous powder. Its molecular formula was determined as n class="Chemical">C19H22O3N by HRESI-MS (m/z 312.1610 [M]+ calcd for C19H22O3N, 312.1599). The 1H-NMR spectrum showed eight olefinic protons, with one AA'BB' system (δH 6.68 and 6.71, both d, J = 8.8 Hz), two singlets at δH 7.07 and 5.90, and two broad signals at δH 6.91 and 6.21. Other signals were attributed to three methyl groups at δH 3.87 (3H, s), 3.52 (3H, s), and 3.22 (3H, s), and an AB2 system at δH 4.60 (dd, J = 11.2, 4.8 Hz), 3.43 (dd, J = 12.4, 4.8 Hz), and 2.92 (dd, J = 12.4, 11.2 Hz). On the basis of the presence of AA'BB' and AB2 systems, the basic structure of the molecule was suggested as that of a benzylisoquinoline. In HMBC spectrum, δH 3.52 (3H, s) and 3.22 (3H, s) were correlated with each other, which indicated the both methyl groups were connected to the same hetero atom. In addition, these two methyl groups were also correlated with δC 76.1 and 131.0 which unveiled the presence of a quaternary amine in its structure (Figure 2).
Figure 2

Key HMBC correlations of compounds 6 and 11.

Key HMBC correlations of n class="Chemical">compounds 6 and 11. Compared with n class="Chemical">magnocurarine, the NMR spectral data of 11 showed some differences, including the absence of two aliphatic carbon signals and the presence of two more olefinic carbons at δC 131.0 and 127.6, all of which implied that 11 possessed one more olefinic bond. The location of the olefinic bond at C-3 and C-4 was inferred by the HMBC correlations of H-5/C-4, N-methyl/C-3, and H-1/C-3. Moreover, the NOE correlation between H-5 and δH 3.87 (3H, s) confirmed the location of methoxy. The absolute configuration of C-1 was established as R by CD spectrum, which showed a negative Cotton effect at 230 nm [10]. Thus, the structure of 11 was elucidated as (R)-3,4-dehydromagnocurarine. Seven known compounds, namely n class="Chemical">(S)-magnoflorine (5) [8], trans/cis N-feruloylputrescine (7/8) [11], (R)-magnocurarine (10) [5], (S)-tembetarine (12) [12], (S)-oblongine (14) [12], and (R)-asimilobine (17) [13] were isolated and their structures were determined by comparing their spectroscopic data with those reported in the literature. The absolute configuration of known compounds 5, 10, 12, 14, and 17 was determined by their CD spectra.

2.2. Bioactivity

Inhibitory activities against aldose reductase (10 µM), lipase (10 µM), α-glucosidase (40 µM), and n class="Chemical">DPP–IV (10 µM) were evaluated for all isolated compounds 5–8, 10–12, 14, and 17. All tested compounds showed weak activities at the same concentration as the positive control drugs (epalrestat, orlistat, acarbose, and INDP-2). The inhibition rates of all tested compounds are all less than 20%. In the cytotoxicity bioassay, isolated compounds (5 µg/mL) showed weak activity against the A549, Bel-7402, and HCT-8 cancer cell lines, while the positive control 5-fluorouracil showed an IC50 value of 0.40 μg/mL.

2.3. HPLC-ESI-MSn Analysis of Alkaloids in M. officinalis

A total of 23 alkaloids were identified or tentatively characterized (Figure 1 and Table 1). n class="Chemical">Comparing the retention times and MSn spectra with those of the corresponding standards, peaks 5–8, 10–12, 14, and 17 could be unambiguously assigned as (S)-magnoflorine (5), (S)-4-keto-magnoflorine (6), trans/cis N-feruloylputrescine (7/8), (R)-magnocurarine (10), (R)-3,4-dehydromagnocurarine (11), (S)-tembetarine (12), (S)-oblongine (14), and (R)-asimilobine (17), respectively (Figure 3). For other alkaloids, the structures were tentatively identified based on their MS fragmentation behavior (Table 1). Accordingly, compounds 1–2, 4–6, 9, and 17–23 were ascribed to aporphine alkaloids, compounds 3, 10, and 11–16 were ascribed to benzylisoquinoline alkaloids. As well known, the two major types of alkaloids which have been found in M. officinalis are the aporphine and benzylisoquinoline ones.
Table 1

Retention time and MS data of alkaloids in stem bark of M. officinalis.

Peak no.tR (min)Proposed compoundsMSESI-MSnm/z (% base peak)
16.3N-Methylocoxylonine (1)400 [M]+MS2 [400]: 369 (10), 355 (100), 337 (15), 323 (95); MS3 [355]: 340 (5), 323 (100), 309 (7); MS3 [323]: 295 (100)
28.71,3,11-Trihydroxy-2,9-dimethoxy-6,6-dimethylaporphinium (2)358 [M]+MS2 [358]: 340 (20), 313 (100), 295 (80), 281 (75); MS3 [313]: 298 (20), 285 (65), 281(90), 253 (100)
39.3N-Methyllaudanidinium (3)358 [M]+MS2 [358]: 340 (11), 313 (100), 295 (60), 221 (54); MS3 [313]: 295 (20), 285 (99), 281 (100), 253 (95)
49.91,9,10-Trihydroxy-2-methoxy-6,6-dimethylaporphinium (4)328 [M]+MS2 [328]: 283 (98), 265(90), 257 (100)
510.8(S)-Magnoflorine (5)342 [M]+MS2 [342]: 311 (20), 297 (100), 265 (53); MS3 [297]: 282 (13), 264 (100), 237 (12)
611.8(S)-4-Keto-magnoflorine (6)356 [M]+MS2 [356]: 311.0 (5), 285 (100); MS3 [285]: 270 (60), 257 (83), 253 (80), 239 (78), 221 (100)
7/812.8trans/cis N-Feruloylputrescine (7/8)265 [M+H]+MS2 [265]: 248 (75), 177 (100); MS3 [177]: 145 (100)
912.9N-Methylbulbocapnine (9)340 [M]+MS2 [340]: 309(5), 295 (100), 203 (17); MS3 [295]: 263 (100)
1014.0(R)-Magnocurarine (10)314 [M]+MS2 [314]: 269 (100), 175 (39), 107 (66); MS3 [269]: 237 (24), 175 (55), 107 (100)
1115.5(R)-3,4-Dehydromagnocurarine (11)312 [M]+MS2 [312]: 205 (100), 190 (20), 145 (11); MS3 [205]: 190.0 (100), 145 (15);
1216.2(S)-Tembetarine (12)344 [M]+MS2 [344]: 299 (99), 175 (100), 137 (83); MS3 [175]: 143 (100)
1316.9Lotusine (13)314 [M]+MS2 [314]: 269 (23), 237 (27), 205 (35), 175 (48),107 (100); MS3 [269]: 175 (99), 107 (100)
1418.4(R)-Oblongine (14)314 [M]+MS2 [314]: 269 (51), 254 (8), 237 (11), 175 (13), 137 (32), 107 (100)
1521.7N-Methylcoclaurine (15)300 [M+H]+MS2 [300]: 269 (100), 237 (10), 192 (15), 107 (50); MS3 [269]: 237 (20), 175 (70), 107 (100)
1623.3Reticuline (16)330 [M+H]+MS2 [330]: 299 (5), 192 (100), 177 (3), 137 (4)
1725.4(R)-Asimilobine (17)268 [M+H]+MS2 [268]: 251 (100), 219 (29); MS3 [251]: 236 (5), 219 (100), 191 (10)
1828.0Corytuberine (18)328 [M+H]+MS2 [328]: 297 (100), 265 (55); MS3 [297]: 265 (100); MS3 [265]: 237 (35), 233 (100)
1931.0Nornuciferine (19)282 [M+H]+MS2 [282]: 265 (100), 250 (5); MS3 [265]: 250 (100), 234 (21)
2032.1Anonaine (20)266 [M+H]+MS2 [266]: 249 (100); MS2 [249]: 219 (100), 191 (30); MS3 [219]: 191 (100)
2132.9Lirinidine (21)282 [M+H]+MS2 [282]: 251 (95), 219 (100), 191 (5); MS2 [251]: 219 (100), 191 (30); MS3 [219]: 191 (100)
2234.5Nandigerine (22)312 [M+H]+MS2 [312]: 295 (100); MS3 [295]: 280 (100), 265 (10), 264 (95), 263 (30)
2339.4Roemerine (23)280 [M+H]+MS2 [280]: 249 (100); MS3 [249]: 219 (100), 191 (50)
Figure 3

LC-UV/MS chromatograms for the alkaloid standards and the alkaloids-enriched extract of M. officinalis. (A) UV chromatogram at 283 nm of the nine alkaloid standards; (B) UV chromatogram at 283 nm and (C) MS TIC chromatogram of the alkaloids-enriched extract. Peak numbers were consistent with those shown in Table 1.

LC-UV/MS chromatograms for the alkaloid standards and the n class="Chemical">alkaloids-enriched extract of M. officinalis. (A) UV chromatogram at 283 nm of the nine alkaloid standards; (B) UV chromatogram at 283 nm and (C) MS TIC chromatogram of the alkaloids-enriched extract. Peak numbers were consistent with those shown in Table 1. Positive ion mode of ESI was selected in the present study. In general, quaternary alkaloids gave [M]+ ions, tertiary and sen class="Chemical">condary alkaloids gave [M+H]+ ions (Table 1). Isolated standards 5 and 17 generated significant [M–(CH3)2NH)]+ or [M+H–NH3]+ fragment ions as the base peak in their respective MS2 spectra, corresponding to quaternary and secondary aporphines, respectively [14]. Based on the mentioned characteristics, compounds 1, 2, 4, and 9 should be quaternary aporphines due to the significant [M–(CH3)2NH]+ fragment ions in their MS2 spectra. Similarly, compounds 19, 20, and 22 should be secondary aporphines due to the significant [M+H–NH3]+ fragment ions in their MS2 spectra. The MS2 fragmentation of compounds 18, 21, and 23 provided significant [M+H–CH3NH2]+ ions in the product-ion spectra, suggesting one methyl group at the nitrogen atom of these compounds. The benzylisoquinoline alkaloids 10 and 12–16 showed obvious cleavages between C-1 and C-1a to produce the significant ion fragments at m/z 107 or 137, which were ascribed to hydroxybenzyl and 3-methoxy-4-hydroxybenzyl fragments, respectively [15]. However, isolated benzylisoquinoline alkaloid 11 gave an ion at m/z 205 as the base peak in the MS2 spectrum, undergoing the loss of a hydroxybenzyl fragment. Similarly, an ion at m/z 221 in MS2 spectra of compound 3 indicated the substituent type of ring C. In the MS2 spectra, compounds 3, 10 and 12–14 showed a characteristic [M-(CH3)2NH]+ loss, whereas compounds 15 and 16 showed a characteristic [M−CH3NH2]+ loss indicating the number of methyl groups at the nitrogen atom. The ion peaks derived from loss of CH3OH, CH3O, H2O, CH3, CO and CH2O were characteristic of aporphine and benzylisoquinoline alkaloids, and served for their structural elucidation [15]. A plausible fragmentation pathway of the representative compounds 11 and 17 is shown in Scheme 1.
Scheme 1

Proposed mechanistic pathway for the fragmentations of alkaloids 6, 7/8, 11, and 17.

Retention time and MS data of alkaloids in stem bark of n class="Species">M. officinalis. Proposed mechanistic pathway for the fragmentations of alkaloids 6, 7/8, 11, and 17. Isolated quaternary alkaloid 6 gave an abnormally weak [M–(n class="Chemical">CH3)2NH]+ fragment ion in the MS2 spectrum, but provided a significant and characteristic [M–C4H9N]+ fragment with m/z 285 as the base peak. Furthermore, the [M–C4H9N]+ fragment undergoes subsequent CH3OH, CO, OH, and CH3 losses. The plausible fragmentation pathway of compound 6 is shown in Scheme 1. The isomers 7 and 8 were eluted in the same peak at 12.8 min, giving [M+H]+ at m/z 265. They produced [M+H−NH3]+ at m/z 248, [M+H−C4n class="Species">H12N2]+ at m/z 177, and [M+H−C4H12N2CH3OH] + at m/z 145 in MS2. The fragmentation pathways proposed for compounds 7 and 8 are shown in Scheme 1.

3. Experimental

3.1. General

Optical rotations were measured on a P2000 automatic digital polarimeter. UV spectra were obtained in MeOH on a Jasn class="Chemical">co V-650 spectrophotometer. IR spectra were recorded in KBr pellets on a Thermo Nicolet 5700 infrared spectrometer. CD spectra were measured on a Jasco J-815 spectropolarimeter. HRESI-MS were obtained on an Agilent 6520 Accurate-Mass Q-TOF LC-MS. NMR spectra were taken on Varian Mercury-400 spectrometer using DSS as references. Strong cation ion exchange resin 001 × 7 was a product of Tianjin Nankai Hecheng S & T Co., Ltd. (Tianjin, China). MCI CHP-20P (Toshiba, 75–150 μm) and RP-C18 (YMC, 40–60 μm) were used for column chromatographic separation. MPLC was performed on an EZ Purifier II flash chromatography system (Shanghai Li Sui E-Tech Co. Ltd. Shanghai, China). Analytical HPLC was conducted on a Waters 2695 pumping system equipped with a Waters 2996 photodiode array detector. The preparative HPLC was performed using a Waters 600 pump, a Waters 2487 detector, and an ODS column (250 mm × 20 mm, 5 μm; YMC). HPLC–MSn analysis was performed with an Agilent G2451AA 6320 Ion Trap LC/MS system. HPLC grade MeCN from Fisher (Fair lawn, NJ, USA) was used for LC-MS/MS analysis. Strata X-C strong cation resin (500 mg/6 mL, Phenomenex, Torrance, CA, USA) was used for SPE. Water was purified with a Milli-Q water purification system (Millipore, Bedford, MA, USA). Ammonium acetate and NH4OH were analytical grade.

3.2. Plant Material

M. officinalis was n class="Chemical">collected from Enshi city, Hubei Province of China, in May 2009, and identified by Prof. Bin Yang. A voucher specimen (NO. 20090518) was deposited at Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences.

3.3. Extraction and Isolation

The dried and powdered stem bark of M. officinalis (25 kg) was extracted with 70% n class="Chemical">ethanol (v/w = 7) under reflux for three times. The aqueous alcohol solutions were combined and concentrated in vacuo to afford a suspension (5 L). The solution obtained was adjusted to pH 1 using HCl and then partitioned three times with 2.5 L of chloroform. After centrifugation, the supernatant of the H2O layer was applied to an ion exchange column (001 × 7; H+ form). The column was washed with 50% EtOH (10 L) and then the eluate of 2M NH4OH (50% EtOH) was collected. The solvent was evaporated under vacuum to yield the alkaloid fraction (73.6 g). The alkaloid fraction was initially chromatographed on a MCI column, eluted with a gradient of EtOH-H2O (0:100 to 95:5), to obtain nine fractions (Fr.1–Fr.9). Fr.2 (15 g, 5% EtOH eluent) was subjected to MPLC over an ODS column, eluted with a MeOH-H2O gradient (10:90 to 50:50) to give 10 (3.9 g) and a mixture of 7 and 8 (5 mg). Fr.3 (11 g, 10% EtOH elute) chromatographed on MPLC over an ODS column, eluted with a MeOH-H2O gradient (10:90 to 50:50) to give compound 5 (5.0 g) and a mixture (100 mg). This mixture was further separated by preparative HPLC (MeCN:0.1% TFA = 12:88, 10 mL/min) to give compounds 11 (14 mg) and 12 (8 mg). Fr.4 (0.5 g, 15% EtOH eluent) was separated by preparative HPLC (MeOH:0.1% TFA = 35:65, 10 mL/min) to give compound 14 (56 mg). Fr.6 (1.2 g, 25% EtOH elute) was subjected to MPLC with an ODS column, eluted with a MeOH-H2O gradient (20:80 to 60:40) to give five subfractions (Fr.6.1–Fr.6.5). Fr.6.3 (40 mg) was separated by preparative HPLC (MeOH:0.1% TFA = 35:65, 10 mL/min) to give compound 6 (10 mg). Fr.7 (1.4 g, 35% EtOH elute) was subjected to MPLC with an ODS column, eluted with a MeOH-H2O gradient (20:80 to 60:40) to give six subfractions (Fr.7.1–Fr.7.6). Fr.7.4 (35 mg) was separated by preparative HPLC (MeOH:0.1% TFA = 30:70, 10 mL/min) to give compound 17 (4 mg). (S)-4-Keto-magnoflorine (6): White amorphous powder; UV (n class="Chemical">MeOH) λmax (nm): 234, 287, 360; [α]20 D +107 (c, 0.11, MeOH); CD Δε (nm): +0.79 (346), –0.29 (297), +0.93 (235) (c = 8.45 × 10−5 M, MeOH); 1H-NMR (D2O, 400 MHz) δH: 6.87 (1H, s, H-3), 6.55 (1H, d, J = 8.0 Hz, H-9), 6.40 (1H, d, J = 8.0 Hz, H-8), 3.91 (2H, brs, H-5), 3.75 (3H, s, 10-OMe), 3.70 (3H, s, 2-OMe), 3.31 (3H, s, N-Me a), 2.82 (3H, s, N-Me b), 2.78 (1H, ov, H-7a), 2.16 (1H, dd, J = 13.2, 12.8 Hz, H-7b); 13C-NMR (D2O, 100 MHz) δC: 189.4 (C-4), 165.2 (C-1), 154.3 (C-2), 151.5 (C-10), 146.6 (C-11), 134.3 (C-11c), 126.4 (C-7a), 124.1 (C-11b), 122.6 (C-11a), 121.2 (C-8), 116.3 (C-3a), 113.1 (C-9), 107.2 (C-3), 71.4 (C-6a), 69.9 (C-5), 58.1 (10-OMe), 58.0 (2-OMe), 56.2 (N-Me a), 48.0 (N-Me b); ESI-MS m/z: 356 [M]+; HRESI-MS m/z: 356.1514 [M]+ (calcd for C20H22O5N, 356.1498; Δ + 4.64 ppm). (R)-3,4-Dehydromagnocurarine (11): White amorphous powder; UV (n class="Chemical">MeOH) λmax (nm): 227, 286; –92 (c, 0.17, MeOH); CD Δε (nm): +0.54 (297), –0.40 (264), –2.63 (230) (c = 6.02 × 10−4 M, MeOH); 1H-NMR (D2O, 400 MHz) δH: 7.07 (1H, s, H-5), 6.91 (1H, brs, H-4), 6.71 (2H, d, J = 8.8 Hz, H-3', 5'), 6.68 (2H, d, J = 8.8 Hz, H-2', 6'), 6.21 (1H, brs, H-3), 5.90 (1H, s, H-8), 4.60 (1H, dd, J = 11.2, 4.8 Hz, H-1), 3.87 (3H, s, 6-OMe), 3.52 (3H, s, N-Me a), 3.43 (1H, dd, J = 12.4, 4.8 Hz, H-1a), 3.22 (3H, s, N-Me b), 2.92 (1H, dd, J = 12.4, 11.2 Hz, H-1a); 13C-NMR (D2O, 100 MHz) δC: 157.4 (C-4'), 150.8 (C-6), 148.9 (C-7), 134.2 (C-2', 6'), 131.0 (C-3), 129.7 (C-1'), 127.6 (C-4), 125.8 (C-8a), 120.8 (C-4a), 119.3 (C-8), 118.0 (C-3', 5'), 114.4 (C-5), 76.2 (C-1), 58.9 (6-OMe), 55.1 (N-Me b), 53.3 (N-Me a), 35.7 (C-1a); ESI-MS m/z: 312 [M]+; HRESI-MS m/z: 312.1610 [M]+ (calcd for C19H22O3N, 312.1599; Δ +3.36 ppm). (S)-Magnoflorine (5): +192 (c, 0.15, n class="Chemical">MeOH); CD Δε (nm): +1.92 (317), –12.29 (267), +38.64 (233) (c = 3.77 × 10−5 M, MeOH) [9]. (R)-Magnocurarine (10): –62 (c, 0.14, n class="Chemical">MeOH); CD Δε (nm): –1.14 (286), –9.59 (231) (c = 1.72 × 10−4 M, MeOH). (S)-Tembetarine (12): +143 (c, 0.11, n class="Chemical">MeOH); CD Δε (nm): +0.89 (286), +2.80 (237) (c = 1.74 × 10−4 M, MeOH). (S)-oblongine (14): +103 (c, 0.23, n class="Chemical">MeOH); CD Δε (nm): –0.59 (272), +1.21 (234) (c = 1.72 × 10−4 M, MeOH). (R)-Asimilobine (17): –186 (c, 0.25, n class="Chemical">MeOH); CD Δε (nm): +11.04 (262), –79.13 (233) (c = 0.97 × 10−5 M, MeOH).

3.4. Assessment of Aldose Reductase, Lipase, α-Glucosidase Inhibitory Activities

See [16].

3.5. Assessment of DPP–IV Inhibitory Activity

See [17].

3.6. Assessment of Cytoxic Activity

See [18].

3.7. Sample Preparation

Compounds 5–8, 10–12, 14, and 17 were isolated by the authors as described above. Their purities were above 95%, as determined by HPLC analysis. Powdered stem bark of M. officinalis (40 mesh, 1.0 g) was extracted with 25 mL 1% n class="Chemical">HCl in an ultrasonic bath (40 kHz) for 30 min. After cooling, the extracted solution was adjusted to the original weight and then filtered. An aliquot of 5 mL of filtrate was passed through Strata X-C strong cation resin (500 mg/6 mL). Wash the column with H2O (5 mL), MeOH (5 mL) and 2M NH4OH-MeOH (5 mL) successively. Collected the last elute and dry under the stream of N2. The residue resolved in MeOH (2 mL). After filtration with 0.22 μm filter, 10 μL of the aliquot was injected for HPLC–MSn analysis.

3.8. Chromatographic and MS Conditions

The sample was separated on a Gemini-NX C18 column (4.6 mm × 250 mm, 5 μm, Phenomenex). The mobile phase was (A) n class="Chemical">CH3CN and (B) 0.1M ammonium acetate (adjust the pH to 7.5 using NH4OH). A gradient program was used as follows: 5–30% A at 0–20 min, 30–60% A at 20–35 min, and 60–90% A at 35–40 min. The column temperature was controlled at 35 °C. The flow rate was 1.0 mL/min. 283 nm was chosen as the detection wavelength. The optimized ESI-MSn parameters in the positive ion mode were as follows: skimmer, 40.0 V; capillary exit, 132.3 V; nebulizer, 42.0 psi; dry temperature, 350 °C; dry gas 12.0 L/min. For full-scan MS analysis, the spectra were recorded in the range of m/z 100–1000. Data-dependent scan program was used in the liquid chromatography/tandem mass spectrometry analysis so that the two most abundant ions in each scan were selected and subjected to MSn (n = 2–3) analyses. The collision-induced dissociation (CID) energy was adjusted to 45%. The isolation width of the precursor ions was 1.0 m/z.

4. Conclusions

In the present study, nine alkaloids including two new n class="Chemical">compounds, (S)-4-keto-magnoflorine (6) and (R)-3,4-dehydromagnocurarine (11), were isolated from the stem bark of M. officinalis. A comprehensive study of alkaloid profile of M. officinalis has been conducted. Twenty three alkaloids including 13 aporphines, eight benzylisoquinolines and two amides were detected and tentatively identified by HPLC-MSn. Nine major alkaloids were unambiguously identified by comparison with isolated standards.
  8 in total

1.  Assessment of the cytotoxic effects of aporphine prototypes on head and neck cancer cells.

Authors:  Dorival Mendes Rodrigues-Junior; Nicolie Melanie de Almeida Pontes; Gabriela Estrela de Albuquerque; Viviane Carlin; Givago Prado Perecim; Cristiano Raminelli; André Luiz Vettore
Journal:  Invest New Drugs       Date:  2019-05-17       Impact factor: 3.850

Review 2.  Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents.

Authors:  Mélanie Poivre; Pierre Duez
Journal:  J Zhejiang Univ Sci B       Date:  2017 Mar.       Impact factor: 3.066

Review 3.  COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy?

Authors:  Dâmaris Silveira; Jose Maria Prieto-Garcia; Fabio Boylan; Omar Estrada; Yris Maria Fonseca-Bazzo; Claudia Masrouah Jamal; Pérola Oliveira Magalhães; Edson Oliveira Pereira; Michal Tomczyk; Michael Heinrich
Journal:  Front Pharmacol       Date:  2020-09-23       Impact factor: 5.810

4.  Application of Multiple-Source Data Fusion for the Discrimination of Two Botanical Origins of Magnolia Officinalis Cortex Based on E-Nose Measurements, E-Tongue Measurements, and Chemical Analysis.

Authors:  Wenguang Jing; Xiaoliang Zhao; Minghua Li; Xiaowen Hu; Xianlong Cheng; Shuangcheng Ma; Feng Wei
Journal:  Molecules       Date:  2022-06-17       Impact factor: 4.927

5.  Croton urucurana Baill. Ameliorates Metabolic Associated Fatty Liver Disease in Rats.

Authors:  Pablo Alvarez Auth; Gustavo Ratti da Silva; Eduarda Carolina Amaral; Victor Fajardo Bortoli; Mariana Inocencio Manzano; Lauro Mera de Souza; Evellyn Claudia Wietzikoski Lovato; João Tadeu Ribeiro-Paes; Arquimedes Gasparotto Junior; Francislaine Aparecida Dos Reis Lívero
Journal:  Front Pharmacol       Date:  2022-05-20       Impact factor: 5.988

6.  A New Oleanane Type Saponin from the Aerial Parts of Nigella sativa with Anti-Oxidant and Anti-Diabetic Potential.

Authors:  Amna Parveen; Muhammad Asim Farooq; Whang Wan Kyunn
Journal:  Molecules       Date:  2020-05-06       Impact factor: 4.411

7.  Water Extract of Piper longum Linn Ameliorates Ovariectomy-Induced Bone Loss by Inhibiting Osteoclast Differentiation.

Authors:  Dong Ryun Gu; Hyun Yang; Seong Cheol Kim; Youn-Hwan Hwang; Hyunil Ha
Journal:  Nutrients       Date:  2022-09-05       Impact factor: 6.706

8.  Variation in the microbial community contributes to the improvement of the main active compounds of Magnolia officinalis Rehd. et Wils in the process of sweating.

Authors:  Qinahua Wu; Dan Wei; Linlin Dong; Yuping Liu; Chaoxiang Ren; Qianqian Liu; Cuiping Chen; Jiang Chen; Jin Pei
Journal:  Chin Med       Date:  2019-10-22       Impact factor: 5.455

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.